Esophageal cancer in the elderly: An analysis of the factors associated with treatment decisions and outcomes

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Tougeron, David ^a   Hamidou, Hadji ^b   Scotté, Michel ^a   Di Fiore, Frédéric ^a   Antonietti, Michel ^a   Paillot, Bernard ^a   Michel, Pierre ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b CRLCC Becquerel   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; IRINOTECAN; ANTINEOPLASTIC AGENT;

AGE; AGED; ARTICLE; ASPIRATION PNEUMONIA; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; ELDERLY CARE; ESOPHAGUS CANCER; ESOPHAGUS DILATATION; ESOPHAGUS RESECTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PHOTODYNAMIC THERAPY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISCERAL METASTASIS; WEIGHT REDUCTION; ESOPHAGUS TUMOR; GERIATRICS; METASTASIS; METHODOLOGY; MIDDLE AGED; ONCOLOGY; PALLIATIVE THERAPY; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ESOPHAGEAL NEOPLASMS; FEMALE; GERIATRICS; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM METASTASIS; PALLIATIVE CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77956903461     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-510     Document Type: Article

References (26)

1. Trivers KF, Sabatino SA, Stewart SL. Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int J Cancer 2008, 123:1422-8. 10.1002/ijc.23691, 18546259.
2. Remontet L, Estève J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, Exbrayat C, Tretare B, Carli PM, Guizard AV, Troussard X, Bercelli P, Colonna M, Halna JM, Hedelin G, Macé-Lesec'h J, Peng J, Buemi A, Velten M, Jougla E, Arveux P, Le Bodic L, Michel E, Sauvage M, Schvartz C, Faivre J. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003, 51:3-30.
3. Bouvier AM, Launoy G, Lepage C, Faivre J. Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther 2005, 22:233-41. 10.1111/j.1365-2036.2005.02559.x, 16091061.
4. Steyerberg EW, Neville B, Weeks JC, Earle CC. Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: a population-based analysis of elderly patients. J Clin Oncol 2007, 25:2389-96. 10.1200/JCO.2006.09.7931, 17557952.
5. Law S, Wong KH, Kwok KF, Chu KM, Wong J. Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 2004, 240:791-800. 10.1097/01.sla.0000143123.24556.1c, 1356484, 15492560.
6. Stahl M, Oliveira J, . ESMO Guidelines Working Group Esophageal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008, 19(Suppl 2):ii21-2. 10.1093/annonc/mdn074, 18456754, ESMO Guidelines Working Group.
7. Kleinberg L, Forastiere AA. Chemoradiation in the management of esophageal cancer. J Clin Oncol 2007, 25:4110-7. 10.1200/JCO.2007.12.0881, 17827461.
8. Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Herr JP, Paillot B, Arveux P, Bonnetain F, Binquet C. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 2007, 25:1160-8. 10.1200/JCO.2005.04.7118, 17401004.
9. Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005, 23:2310-2317. 10.1200/JCO.2005.00.034, 15800321.
10. Anderson SE, Minsky BD, Bains M, Hummer A, Kelsen D, Ilson DH. Combined modality chemoradiation in elderly oesophageal cancer patients. Br J Cancer 2007, 96:1823-1827. 10.1038/sj.bjc.6603821, 2359964, 17533399.
11. Tougeron D, Di Fiore F, Thureau S, Berbera N, Iwanicki-Caron I, Hamidou H, Paillot B, Michel P. Definitive chemoradiotherapy in elderly patients with an oesophageal cancer: A good alternative treatment in inoperable or locally advanced cancer. Br J Cancer 2008, 99:1586-92. 10.1038/sj.bjc.6604749, 2584940, 19002180.
12. Atkinson M. Diseases of the alimentary system. Dysphagia. Br Med J 1977, 1:91-93. 10.1136/bmj.1.6053.91, 1604049, 832026.
13. Charlson ME, Sax FL, MacKenzie CR, Braham RL, Fields SD, Douglas RG. Morbidity during hospitalization: can we predict it?. J Chron Dis 1997, 40:373-383.
14. Ell C, May A, Gossner L, Pech O, Günter E, Mayer G, Henrich R, Vieth M, Müller H, Seitz G, Stolte M. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000, 118:670-7. 10.1016/S0016-5085(00)70136-3, 10734018.
15. Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992, 326:1593-98. 10.1056/NEJM199206113262403, 1584260.
16. Michel P, Adenis A, Di Fiore F, Boucher E, Galais MP, Dahan L, Mirabel X, Hamidou H, Raoul JL, Jacob JH, Hellot MF, Prod'homme S, Paillot B. Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial. Br J Cancer 2006, 95:705-709. 10.1038/sj.bjc.6603328, 2360517, 16967056.
17. Arias E. United States Life Tables, 2003. National vital statistics reports 2006, 54(14). Hyattsville, MD: National Center for Health Statistics., http://www.cdc.gov/nchs/data/nvsr/nvsr54/nvsr54_14.pdf
18. Pech O, May A, Rabenstein T, Ell C. Endoscopic resection of early oesophageal cancer. Gut 2007, 56:1625-34. 10.1136/gut.2006.112110, 17938435.
19. Sibille A, Lambert R, Souquet JC, Sabben G, Descos F. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995, 108:337-44. 10.1016/0016-5085(95)90058-6, 7835574.
20. Sabel MS, Smith JL, Nava HR, Mollen K, Douglass HO, Gibbs JF. Esophageal resection for carcinoma in patients older than 70 years. Ann Surg Oncol 2002, 9:210-4. 10.1007/BF02557376, 11888881.
21. Gockel I, Sultanov FS, Domeyer M, Goenner U, Junginger T. Developments in esophageal surgery for adenocarcinoma: a comparison of two decades. BMC Cancer 2007, 7:114. 10.1186/1471-2407-7-114, 1914077, 17603896.
22. Internullo E, Moons J, Nafteux P, Coosemans W, Decker G, De Leyn P, Van Raemdonck D, Lerut T. Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years. Eur J Cardiothorac Surg 2008, 33:1096-104. 10.1016/j.ejcts.2008.03.004, 18407509.
23. Bleiberg H, Conroy T, Paillot B, Lacave AJ, Blijham G, Jacob JH, Bedenne L, Namer M, De Besi P, Gay F, Collette L, Sahmoud T. Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer 1997, 33:1216-20. 10.1016/S0959-8049(97)00088-9, 9301445.
24. Trumper M, Ross PJ, Cunningham D, Norman AR, Hawkins R, Seymour M, Harper P, Iveson T, Nicolson M, Hickish T. Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials. Eur J Cancer 2006, 42:827-34. 10.1016/j.ejca.2005.08.044, 16466913.
25. Polee MB, Hop WC, Kok TC, Eskens FA, van der Burg ME, Splinter TA, Siersema PD, Tilanus HW, Stoter G, van der Gaast A. Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br J Cancer 2003, 89:2045-2050. 10.1038/sj.bjc.6601364, 2376851, 14647136.
26. Di Fiore F, Lecleire S, Pop D, Rigal O, Hamidou H, Paillot B, Ducrotté P, Lerebours E, Michel P. Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer. Am J Gastroenterol 2007, 102:2557-63. 10.1111/j.1572-0241.2007.01437.x, 17680847.